Company Analysis

Kestra Medical Technologies, Ltd. (KMTS)

Nasdaq: KMTS · Surgical & Medical Instruments & Apparatus · Kirkland, WA · filing with the SEC since 2021
Grade5.8
◀ Past 6.4● Present 5.5▶ Future 5.6
3 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in April.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024
Period endingApr 30, 2026Apr 30, 2025Apr 30, 2024
Report filedJul 14, 2026Jul 17, 2025·
Revenue95,126.059,815.027,814.0
Cost of revenue46,263.035,605.027,452.0
Gross profit48,863.024,210.0362.0
Research and development19,484.015,652.015,490.0
Selling, general and administrative164,120.0114,936.069,935.0
Total operating expenses183,604.0130,588.085,425.0
Operating income-134,741.0-106,378.0-85,063.0
Interest expense7,546.07,734.06,230.0
Interest and investment income8,351.03,199.0·
Other income (expense), net2,618.0-2,766.0-2,803.0
Income before income taxes-131,318.0-113,679.0-94,096.0
Income tax expense294.0135.024.0
Net income including non-controlling interests-131,612.0-113,814.0-94,120.0
Net income-131,612.0-113,814.0-94,120.0
Preferred dividends·12,321.06,721.0
Net income to common shareholders-131,612.0-126,135.0-100,841.0
Earnings per share, basic-2.43-5.13-5.07
Earnings per share, diluted-2.43-5.13-5.07
Weighted average shares, basic54,184,69824,583,74519,885,382
Weighted average shares, diluted54,184,69824,583,74519,885,382
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton KMTS · research, not advice